Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

NCT06279754 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Squamous Non-small Cell Lung Cancer

Interventions

DRUG: Recombinant Human Endostatin Injection

Sponsor

The First Affiliated Hospital of Xinxiang Medical College